RenovoRx(RNXT) - 2025 Q4 - Earnings Call Transcript

RenovoRx (NasdaqCM:RNXT) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsJustin Walsh - Director of HealthcareMark Voll - CFORamtin Agah - Executive Chairman and FounderShaun Bagai - CEOValter Pinto - Managing DirectorConference Call ParticipantsEdward Woo - Director of Research and Senior AnalystScott Henry - Managing Director and Senior Research AnalystSwayampakula Ramakanth - Managing Director of Equity Research and Senior Healthcare AnalystOperatorGood afternoon. I'll be your confer ...